Many companies just iterate indefinitely without ever making progress toward an actual drug,” said one biotech VC on a panel ...

At an event hosted by BioPharma Dive, drugmaker executives and investors discussed the importance of focus, smart spending ...

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...

Should you forget Eli Lilly and buy this magnificent biotech instead? Let's find out.

Trump Picks RFK for HHS Though it’s been less than a month since the U.S. presidential election, Wall Street investors are ...

Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Merck MRK announced that it has entered into an exclusive licensing deal with China-based privately-held biotech company ...

Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...

These days, it’s rarer to see a scientist controlling the company they founded. Biotech is a much larger enterprise now than it was in the 1970s, but it’s just as risky. About 90% of drug ...